Eli Lilly and Company (LLY)
FSX
Real-time Data
06:00 AM
Day's Range
1,029.8052 wk Range
664.60Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
851.16B
P/E (Trailing)
‪38.88‬
P/E (Forward)
‪48.12‬
PEG Ratio
‪1.47‬
Price / Sales (TTM)
‪11.42‬
Price / Book
‪31.26‬
EV / EBITDA
‪22.92‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.30%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪1,023.02‬
200-Day Avg
‪925.18‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Market Cap - LLY - Eli Lilly and Company
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular care, serving patients,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
